Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors.
Teh JLF, Erkes DA, Cheng PF, Tiago M, Wilski NA, Field CO, Chervoneva I, Levesque MP, Xu X, Dummer R, Aplin AE.
Teh JLF, et al. Among authors: wilski na.
Cancer Immunol Res. 2020 Sep;8(9):1114-1121. doi: 10.1158/2326-6066.CIR-19-0743. Epub 2020 Jul 13.
Cancer Immunol Res. 2020.
PMID: 32661093
Free PMC article.